Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARNC
4826
PUT
DELISTED
Arconic Corporation
ARNC
| $2.42M | ﹤0.01% |
81,275
+48,375
| +147% | +$1.27M |
|
4827
OraSure Technologies
OSUR
$263M
| $2.42M | ﹤0.01% |
228,775
-163,579
| -42% | -$2.15M |
|
4828
AppFolio
APPF
$6.94B
| $2.42M | ﹤0.01% |
13,435
+4,092
| +44% | +$655K |
|
|
RWT
4829
PUT
Redwood Trust
RWT
$603M
| $2.42M | ﹤0.01% |
275,500
-34,600
| -11% | -$298K |
|
|
FLIR
4830
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $2.42M | ﹤0.01% |
55,139
+26,629
| +93% | +$1.03M |
|
|
EVRI
4831
DELISTED
Everi Holdings
EVRI
| $2.42M | ﹤0.01% |
174,977
-450,150
| -72% | -$4.89M |
|
4832
ABM Industries
ABM
$2.8B
| $2.42M | ﹤0.01% |
63,824
-33,604
| -34% | -$1.27M |
|
|
LKFT
4833
PUT
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.8B
| $2.42M | ﹤0.01% |
24,400
-7,600
| -24% | -$929K |
|
4834
State Street SPDR S&P Capital Markets ETF
KCE
$475M
| $2.42M | ﹤0.01% |
32,070
-22,187
| -41% | -$1.5M |
|
4835
PUT
Keurig Dr Pepper
KDP
$41.2B
| $2.41M | ﹤0.01% |
75,400
-223,600
| -75% | -$6.62M |
|
|
VRNT
4836
PUT
DELISTED
Verint Systems
VRNT
| $2.41M | ﹤0.01% |
70,472
-78,716
| -53% | -$2.24M |
|
|
SPXB
4837
DELISTED
ProShares S&P 500 Bond ETF
SPXB
| $2.41M | ﹤0.01% |
+25,518
| New | +$2.38M |
|
|
CBAY
4838
PUT
DELISTED
Cymabay Therapeutics
CBAY
| $2.41M | ﹤0.01% |
419,900
+386,500
| +1,157% | +$2.93M |
|
4839
Orthofix Medical
OFIX
$409M
| $2.41M | ﹤0.01% |
56,015
+13,523
| +32% | +$494K |
|
|
SAFE
4840
CALL
DELISTED
Safehold Inc.
SAFE
| $2.41M | ﹤0.01% |
33,200
-17,000
| -34% | -$1.16M |
|
|
DRNA
4841
PUT
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.41M | ﹤0.01% |
109,200
+97,600
| +841% | +$2.15M |
|
4842
CALL
Pitney Bowes
PBI
$2.2B
| $2.4M | ﹤0.01% |
390,300
+163,100
| +72% | +$980K |
|
4843
Invesco S&P SmallCap Health Care ETF
PSCH
$184M
| $2.4M | ﹤0.01% |
42,471
+22,848
| +116% | +$1.14M |
|
4844
iShares ESG Aware 1-5 Year USD Corporate Bond ETF
SUSB
$1.31B
| $2.4M | ﹤0.01% |
+91,692
| New | +$2.39M |
|
4845
CALL
Fortune Brands Innovations
FBIN
$5.56B
| $2.4M | ﹤0.01% |
32,760
+20,007
| +157% | +$1.46M |
|
|
CIM
4846
PUT
Chimera Investment
CIM
$983M
| $2.4M | ﹤0.01% |
78,000
+48,433
| +164% | +$1.4M |
|
4847
CALL
UBS Group
UBS
$175B
| $2.4M | ﹤0.01% |
169,800
+38,000
| +29% | +$503K |
|
4848
PUT
Ultragenyx Pharmaceutical
RARE
$2.58B
| $2.4M | ﹤0.01% |
17,300
+14,800
| +592% | +$1.76M |
|
|
KYNB
4849
Kyntra Bio
KYNB
$27.6M
| $2.39M | ﹤0.01% |
2,581
-3,454
| -57% | -$3.63M |
|
4850
PUT
Ionis Pharmaceuticals
IONS
$9.74B
| $2.39M | ﹤0.01% |
42,300
+20,000
| +90% | +$997K |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.